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Conclusion: Clinical outcomes after re-operative CABG remained constant during the 
period from 1985 to 2001 despite increasing age and comorbidities among patients.
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809-2 The Impact of Deep Sternal Wound Infection on Long-
Term Survival After Coronary Artery Bypass Grafting
Ioannis K. Toumpoulis, Constantine E. Anagnostopoulos, Joseph J. DeRose, Daniel G. 
Swistel, St. Luke's/Roosevelt Hospital Center at Columbia University, New York, NY, 
University Hospital of Ioannina, Ioannina, Greece
Background. To identify the impact of deep strernal wound infection (DSWI) on long-term
survival after coronary artery bypass grafting (CABG).
Methods. We studied 3760 consecutive patients who underwent isolated CABG between
1992 and 2002. Patients with CABG and no DSWI were compared with those who devel-
oped DSWI. Long-term survival data were obtained from the National Death Index.
Groups were compared by Cox proportional hazard models and Kaplan-Meier survival
plots. The propensity for DSWI was determined by logistic regression analysis and each
patient with DSWI was then matched to 10 patients without DSWI.
Results. Forty patients (1.1%) developed DSWI. Multivariate logistic regression analysis
found that the independent predictors of DSWI were diabetes mellitus (odds ratio (OR)
5.5; P<0.001), hemodynamic instability (OR 4.0; P=0.026), use of bilateral internal tho-
racic arteries (OR 2.6; P=0.010), endocarditis and/or sepsis (OR 29.9; P<0.001) and
dialysis (OR 3.4; P=0.049). There were no differences in thirty-day mortality between
matched groups. Patients with DSWI had longer length of stay (35.0 versus 16.4 days;
P<0.001). Kaplan-Meier curves of the two matched groups are shown in figure. After
adjustment for pre, intra and postoperative factors, the adjusted hazard ratio of long-term
mortality for patients with DSWI was 2.44 (95%CI 1.51-3.92; P<0.001).
Conclusions. We found that DSWI after CABG operations was associated with increased
long-term mortality.
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809-3 Coronary Artery Bypass Grafting Without 
Cardiopulmonary Bypass Increases Survival Rate and 
Decreases Morbidity: A Meta-Analysis
Katherine J. Deans, Peter C. Minneci, Steven M. Banks, Michael A. Solomon, Thomas E. 
MacGillivray, William D. Hoffman, Charles Natanson, Gus J. Vlahakes, National Institutes 
of Health, Bethesda, MD, Massachusetts General Hospital and Harvard Medical School, 
Boston, MA
Background: A meta-analysis was performed to identify significant differences in out-
come between CABG with cardiopulmonary bypass (CPB) and CABG without CPB, “off-
pump” CABG.
Methods: 41 studies that provided 30 day mortality data on off-pump CABG compared to
CABG using CPB were analyzed for differences in study design, pre-operative demo-
graphics, operative strategy, post-operative morbidity, and survival rates.
Results: In 8 of the 10 studies performed prior to 1996, off-pump CABG was associated
with a significant 30 day survival rate disadvantage (odds ratio of survival 0.73; 95% CI
0.56 – 0.94; p = 0.02). These 8 studies reported a higher percentage of females undergo-
ing off-pump surgery compared to CABG with CPB . However, off-pump CABG was
associated with significant improvements in both 30 day and 15 month average survival
rates in the 31 studies performed after 1995, even when there were proportionately more
females undergoing off pump surgery compared to CABG with CPB (30 day odds ratio of
survival 1.56; 95% CI 1.33-1.84; p = 0.001; 15 month average follow-up odds ratio of sur-
vival 1.89, 95% CI 1.24-2.89, p=0.001). Furthermore, post-operative morbidity was signif-
icantly less in patients who underwent off-pump CABG versus CABG with CPB after
1995. Commercially available cardiac stabilization devices, which became available in
1996, were uniformly used in 30 of the 31 studies after 1995, but were not consistently
employed in the 10 studies performed before 1996 (30/31 v. 0/10, p = 0.00001). These
devices could be particularly important in the treatment of women, who have smaller
diameter coronary vessels which are more technically challenging to bypass.
Conclusions: Compared to CABG with CPB, off-pump CABG improves both short term
and long term survival rates. These improvements in survival rates correlate with the use
of commercially available stabilization devices, which may be particularly important in
women. Furthermore, off-pump CABG is associated with markedly decreased post-oper-
ative morbidity. This suggests that off-pump CABG using commercially available stabili-
zation devices should be the preferred method for surgical coronary revascularization.
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809-4 Impact of Diabetes on 12-Month Outcomes Following 
Coronary Artery Bypass Graft Surgery: Results From 
the Routine Versus Selective Exercise Treadmill Testing 
After Coronary Artery Bypass Grafting (ROSETTA-
CABG) Registry
Melissa Gitman, Karen Okrainec, Hiep Nguyen, Robert Duerr, Michael Del Core, 
Dominique Fourchy, Thao Huynh, Ellis Lader, Felix J. Rogers, M. Rashid Chaudry, Louise 
Pilote, Mark J. Eisenberg, The ROSETTA-CABG Investigators, Jewish General Hospital/
McGill University, Montreal, PQ, Canada
Background: Little is known about the impact of diabetes mellitus on outcomes during the
first 12 months following CABG.
Objectives: The purpose of our study was to examine the relationship between diabetes
mellitus and clinical outcomes during the first 12 months following CABG.
Methods: The ROSETTA-CABG Registry is a prospective multicenter study examining
the use of functional testing after CABG. We examined 363 diabetic and non-diabetic
patients enrolled in the registry at 16 clinical centers in 6 countries. Diabetes status was
defined by medication use at discharge. Only patients undergoing a first successful iso-
lated CABG in which all ischemic areas were thought to be revascularized were included.
Results: Among the 363 patients, 34 (8.9%) were receiving insulin at discharge, 62
(16.2%) were receiving oral hypoglycemic agents, and 267 (69.5%) were not receiving
insulin or oral hypoglycemic agents. The patients were predominantly elderly men (mean
age 63.2 + 10.2, 81.0% male). The mean number of arteries bypassed was 3.6 + 1.3.
Insulin-treated patients had a higher incidence of composite clinical events (unstable
angina, myocardial infarction, death) compared with patients receiving oral hypoglycemic
agents and non-diabetic patients (17.6% versus 3.2% and 6.1%, respectively, insulin vs
non-insulin p=0.02). There was also a trend for insulin-treated patients to have a higher
incidence of composite procedural events (cardiac catheterization, PCI, repeat CABG)
compared with patients receiving oral hypoglycemic agents and non-diabetic patients
(11.8% versus 4.9% and 3.8% respectively, insulin vs non-insulin p=0.07). After control-
ling for baseline clinical characteristics, insulin use at discharge had a persistent associa-
tion with composite clinical events (OR=3.19, 95% CI=1.07-9.56, p=0.04).
Conclusions: During the 12-month period after a successful CABG, insulin-treated
patients have a higher rate of adverse events compared with patients receiving oral
hypoglycemic agents and non-diabetic patients. These results suggest that diabetic
patients may benefit from more aggressive surveillance following CABG.
Variable 1985-1989
(n=740)
1990-1993
(n=791)
1994-1997
(n=733)
1998-2001
(n=506)
Age (years) 60.6 64.0 63.9 66.0 <0.0001
Female (%) 13.8 15.3 15.4 15.6 0.83
Diabetes (%) 22.0 23.7 32.8 32.4 <0.0001
Hypertension (%) 47.4 51.5 63.9 74.2 <0.0001
Previous MI (%) 61.0 66.6 73.3 74.2 <0.0001
CCS III or IV (%) 78.9 79.9 77.3 71.4 0.0098
Congestive HF (%) 21.4 12.5 14.5 25.7 <0.0001
Ejection fraction (%) 50.8±13.2 48.1±13.3 47.8±12.5 46.6±11.9 <0.0001
Elective operation (%) 87.0 90.1 91.4 92.5 0.0005
3-vessel disease or left 
main (%)
78.2 83.4 81.0 83.9 0.0032
Time between first and 
redo CABG (years)
8.20±3.38 9.77±3.94 11.0±5.12 11.53±6.04 <0.0001
Post-procedure hospital 
stay (days)
10.28±11.0 10.43±10.2 7.79±8.5 8.35±9.9 <0.0001
In-hospital mortality (%) 6.37 6.84 7.50 6.72 0.86
